Remove CMS Remove Reimbursement Remove Stroke
article thumbnail

AI-ECG’s 2025 Kickoff

CardiacWire

Ultimately, the study found that patient AIRE scores accurately predicted CV death (HR: 2.24), HF risk (HR: 2.60), MI (HR: 3.13), ischemic stroke (HR: 1.23), and CKD (HR: 1.89) compared to traditional risk factors. AIRE-HTN was trained on ~190k patients at Beth Israel Deaconess and validated on 65k patients from UK Biobank.

article thumbnail

Abstract NS8: Enhancing Post-Stroke Care: Implementing the Transitional Care Model

Stroke Journal

Stroke, Volume 56, Issue Suppl_1 , Page ANS8-ANS8, February 1, 2025. Background and Purpose:Patients discharged home after a stroke are particularly vulnerable during the immediate post-discharge period. Patients were seen by the outpatient stroke NP within 7 to 14 days, either in clinic or via telemedicine.

CMS 40
article thumbnail

Abstract WMP82: Stroke Transitional Care Model: An Advanced Practice Provider Led Initiative

Stroke Journal

Stroke, Volume 56, Issue Suppl_1 , Page AWMP82-AWMP82, February 1, 2025. Our Comprehensive Stroke Center identified critical gaps in post-discharge care, including inconsistent follow-up timing and a high rate of missed appointments.

CMS 40
article thumbnail

Biocardia Reports Positive Interim Results from Phase III Cardiamp Cell Therapy Heart Failure Trial, with Compelling Data in Subgroup with Elevated NTproBNP Biomarker for Heart Failure

DAIC

The CardiAMP HF trial is supported by the Maryland Stem Cell Research Fund and has reimbursement from the Centers for Medicare and Medicaid Services (CMS) for both treatment and control procedures. The CardiAMP HF II trial is expected to similarly secure CMS reimbursement. vs. 13.2%, respectively).